Related references
Note: Only part of the references are listed.Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
Vincent Billioud et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
David S. Kotlyar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Does Anti-TNF Therapy Reduce the Requirement for Surgery in Ulcerative Colitis? A Systematic Review
Jerome Filippi et al.
CURRENT DRUG TARGETS (2011)
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
Walter Reinisch et al.
GUT (2011)
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
Laurent Peyrin-Biroulet et al.
GUT (2011)
Optimizing Thiopurine Therapy in Inflammatory Bowel Disease
Jean-Baptiste Chevaux et al.
INFLAMMATORY BOWEL DISEASES (2011)
Recent advances in cytokines: Therapeutic implications for inflammatory bowel diseases
Guillaume Bouguen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Infliximab for refractory ulcerative proctitis
G. Bouguen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy, and Hospitalization
Abderrahim Oussalah et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
Waqqas Afif et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data
Stefan Schreiber et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
Asher Kornbluth et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Long-Term Antibiotic Treatment for Crohn's Disease: Systematic Review and Meta-Analysis of Placebo-Controlled Trials
Martin Feller et al.
CLINICAL INFECTIOUS DISEASES (2010)
Efficacy of TNF Antagonists Beyond One Year in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Review
Abderrahim Oussalah et al.
CURRENT DRUG TARGETS (2010)
Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2010)
Early Crohn disease: a proposed definition for use in disease-modification trials
Laurent Peyrin-Biroulet et al.
GUT (2010)
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates
A. V. Ramadas et al.
GUT (2010)
Disability in Inflammatory Bowel Diseases: Developing ICF Core Sets for Patients with Inflammatory Bowel Diseases Based on the International Classification of Functioning, Disability, and Health
Laurent Peyrin-Biroulet et al.
INFLAMMATORY BOWEL DISEASES (2010)
Efficacy of Methotrexate in Ulcerative Colitis: Failure or Promise
Hans H. Herfarth et al.
INFLAMMATORY BOWEL DISEASES (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
Gert Van Assche et al.
JOURNAL OF CROHNS & COLITIS (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab
C. Ma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
M. Allez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Antibiotics and probiotics in inflammatory bowel disease: why, when, and how
Cosimo Prantera et al.
CURRENT OPINION IN GASTROENTEROLOGY (2009)
Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
Konstantinos Karmiris et al.
GASTROENTEROLOGY (2009)
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
William J. Sandborn et al.
GASTROENTEROLOGY (2009)
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
F. Schnitzler et al.
GUT (2009)
Use of new once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis: Is there anything new under the sun?
Peter Laszlo Lakatos
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Increased Efficacy of Delayed-Release Mesalamine 4.8g/D (800mg Tablet) in Patients Previously Diagnosed with Ulcerative Colitis (UC)
William J. Sandborn et al.
GASTROENTEROLOGY (2009)
Defining the Optimal Response Criteria for the Crohn's Disease Activity Index for Induction Studies in Patients With Mildly to Moderately Active Crohn's Disease
Kelvin T. Thia et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study
Brian G. Feagan et al.
GASTROENTEROLOGY (2008)
Risk factors for opportunistic infections in patients with inflammatory bowel disease
Murat Toruner et al.
GASTROENTEROLOGY (2008)
European evidence-based Consensus on the management of ulcerative colitis: Current management
S. P. L. Travis et al.
JOURNAL OF CROHNS & COLITIS (2008)
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
E. F. Stange et al.
JOURNAL OF CROHNS & COLITIS (2008)
Long-term outcome after infliximab for refractory ulcerative colitis
Marc Ferrante et al.
JOURNAL OF CROHNS & COLITIS (2008)
A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: A case for subcutaneous administration
Debbie M. Nathan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Crohn's disease: beyond antagonists of tumour necrosis factor
Laurent Peyrin-Biroulet et al.
LANCET (2008)
Nutritional therapy fair active Crohn's disease
Paul A. Smith
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared with 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial
Stephen B. Hanauer et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial
William J. Sandborn et al.
ANNALS OF INTERNAL MEDICINE (2007)
Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies
S. Plamondon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
Geert D'Haens et al.
GASTROENTEROLOGY (2007)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study
P Marteau et al.
GUT (2005)
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis:: A randomized, placebo-controlled study
G Järnerot et al.
GASTROENTEROLOGY (2005)
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease
GR Lichtenstein et al.
GASTROENTEROLOGY (2005)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease
P Rutgeerts et al.
GASTROENTEROLOGY (2004)
Infliximab in inflammatory bowel disease:: clinical outcome in a population based cohort from Stockholm County
T Ljung et al.
GUT (2004)
A review of activity indices and efficacy Endpoints for clinical trials of medical therapy in adults with Crohn's disease
WJ Sandborn et al.
GASTROENTEROLOGY (2002)
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
WA Faubion et al.
GASTROENTEROLOGY (2001)